BioCentury | Nov 21, 2020
Finance

Mei readies Antengene to take its next steps to becoming a global biotech

...on the Hong Kong stock exchange, Shanghai’s Antengene...
...out its pipeline and launching its first drug.Antengene Corp. Ltd....
...held a 6% stake going into the offering.Antengene...
BioCentury | Aug 29, 2020
Finance

Aug. 28 Quick Takes: Synthego raises $100M D round, plus Clene, Aetion, Antengene, Athira, Compass

...Fight Against COVID-19”).Antengene files for HK IPOOne month after raising its $97 million series C, Antengene...
...developing COMP360, a high-purity polymorphic crystalline formulation of psilocybin, for treatment-resistant depression. BC Staff Synthego Corp. Clene Nanomedicine Inc. Antengene...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...the German government (see “GSK-CureVac Deal” ). Fidelity leads Antengene C round Shanghai cancer company Antengene...
BioCentury | Jun 10, 2020
Management Tracks

iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more

...C in May, bringing the total funds raised in the round to over $90 million. Antengene...
...plc (NASDAQ:ALKS). Robin Sawka, BioCentury Staff Constellation Pharmaceuticals Inc. Inspire Medical Systems Inc. Akcea Therapeutics Inc. iTeos Therapeutics S.A. Amplyx Pharmaceuticals Inc. Antengene...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...CEO of Achillion Pharmaceuticals Inc., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in January. Cancer company Antengene...
...Ladonchamps, ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB (SSE:SOBI). China-focused cancer company Antengene...
...search and evaluation at BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene...
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...President Sarah Boyce and COO Jeff Goldberg (see “Unexpected Shakeup at Akcea” ). Cancer company Antengene...
BioCentury | Dec 20, 2019
Product Development

Pharma spinouts: a snapshot of where and how pharmas spin out their assets

...pharma spinouts, five companies were spun out in China. In 2017, Celgene Corp. spun out Antengene...
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...Medical Technology licensed AZD3229, a c-Kit inhibitor; Antengene...
...Lilly and Co. Novoheart Holdings Inc. Sun Pharmaceutical Industries Ltd. Antengene...
BioCentury | Jan 4, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Korea and other East and Southeast Asian territories, excluding Japan (see "Celgene, Antengene Deal" ). Antengene...
Items per page:
1 - 10 of 20
BioCentury | Nov 21, 2020
Finance

Mei readies Antengene to take its next steps to becoming a global biotech

...on the Hong Kong stock exchange, Shanghai’s Antengene...
...out its pipeline and launching its first drug.Antengene Corp. Ltd....
...held a 6% stake going into the offering.Antengene...
BioCentury | Aug 29, 2020
Finance

Aug. 28 Quick Takes: Synthego raises $100M D round, plus Clene, Aetion, Antengene, Athira, Compass

...Fight Against COVID-19”).Antengene files for HK IPOOne month after raising its $97 million series C, Antengene...
...developing COMP360, a high-purity polymorphic crystalline formulation of psilocybin, for treatment-resistant depression. BC Staff Synthego Corp. Clene Nanomedicine Inc. Antengene...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...the German government (see “GSK-CureVac Deal” ). Fidelity leads Antengene C round Shanghai cancer company Antengene...
BioCentury | Jun 10, 2020
Management Tracks

iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more

...C in May, bringing the total funds raised in the round to over $90 million. Antengene...
...plc (NASDAQ:ALKS). Robin Sawka, BioCentury Staff Constellation Pharmaceuticals Inc. Inspire Medical Systems Inc. Akcea Therapeutics Inc. iTeos Therapeutics S.A. Amplyx Pharmaceuticals Inc. Antengene...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...CEO of Achillion Pharmaceuticals Inc., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in January. Cancer company Antengene...
...Ladonchamps, ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB (SSE:SOBI). China-focused cancer company Antengene...
...search and evaluation at BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene...
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...President Sarah Boyce and COO Jeff Goldberg (see “Unexpected Shakeup at Akcea” ). Cancer company Antengene...
BioCentury | Dec 20, 2019
Product Development

Pharma spinouts: a snapshot of where and how pharmas spin out their assets

...pharma spinouts, five companies were spun out in China. In 2017, Celgene Corp. spun out Antengene...
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...Medical Technology licensed AZD3229, a c-Kit inhibitor; Antengene...
...Lilly and Co. Novoheart Holdings Inc. Sun Pharmaceutical Industries Ltd. Antengene...
BioCentury | Jan 4, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Korea and other East and Southeast Asian territories, excluding Japan (see "Celgene, Antengene Deal" ). Antengene...
Items per page:
1 - 10 of 20